Latest News, Press Releases & Events

Spyryx Biosciences Expands with Election of Roger Jeffs, PhD as Independent Director

– Recognized Biotech Leader With Extensive Experience in Respiratory Product Development and Rare Diseases DURHAM, N.C., Jan. 16, 2018 /PRNewswire/ — Spyryx Biosciences, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for severe pulmonary diseases, announced today the election of Dr. Roger Jeffs as a member of the Company’s board of directors. Dr. Jeffs brings […]

Continue Reading